pembrolizumab,melphalan
gsk,merck
['melphalan', 'pembro', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
dr. solomon presents auto hct with flu/mel and pembro in aml (ineligible for allo), n=20, os over 60% at 3 yr, those with irae had better os, mostly comparable os with allo cohort, slightly higher release risk, interesting! #ash22 
Hem/Onc, BMT, CAR-T, Immunology, Math, Machine Learning, Python, R, SAS. Tweets are my personal views